Overview
This page covers Bowen therapy, also called the Bowen technique: a hands-on method attributed to the Australian practitioner Thomas Bowen (1916-1982) and taught today by several separate schools. It sets out how the names are used, what a session is reported to involve, which conditions have been studied, what a systematic review and small controlled trials found, and what trial reports and a UK professional register say about safety and training. It is unrelated to Bowen's disease, a skin condition.
Where does Bowen Therapy come from?
Attribution to Thomas Bowen
Trial reports from Hong Kong and Pakistan attribute the method to Thomas Bowen (1916-1982), an Australian, and place its development in the 1950s. One of them calls him an osteopath, while another calls the technique a holistic bodywork method developed by the late Tom Bowen. The reports give no biographical sources for these statements, and they are brief background passages in clinical papers, not historical research.
Schools and lineages
The sources reviewed show several separate teaching bodies. A UK register lists approved Bowen courses from Bowen College UK, from Bowtech through the Bowen Therapy Academy of Australia, and from the College of Bowen Studies. The Hong Kong trials were delivered by occupational therapists certified by the International School of Bowen Therapy (ISBT). A 2011 systematic review searched under four names: Bowen Technique, Bowen Therapy, Bowtech and Bowenwork.
What the sources do not establish
No biography, archive or scholarly history of Bowen was opened for this page. His training, the size of his practice, how the method passed to later teachers and how the competing schools relate to each other are therefore not described here. Accounts of those points circulate widely, but they were not verified against a source a reader can open for free. An early case series described the therapy as established, with anecdotal reports of effectiveness and limited published research.
What do the names and terms mean?
Names in use
The same family of methods appears under several names: Bowen therapy, the Bowen technique, Bowenwork and Bowtech. Trial authors also write ISBT-Bowen Therapy for the version taught by the International School of Bowen Therapy, and one pilot study uses the phrase fascia Bowen therapy. The UK register lists its approved courses under titles such as Bowen Therapeutic Technique and Certified Bowen Healthcare Therapist. The sources do not say whether these names refer to identical methods.
Moves, sequences and pauses
Trial reports use the word move for a single rolling action over a muscle, tendon or other soft tissue, and sequence for a named group of moves. Hong Kong protocols use sequence numbers and sequences named Kidney and Asthma. Those names are labels within the method, and the trial reports do not present them as evidence that the method acts on those organs. A pause of about two minutes between moves is a recurring feature of the descriptions.
Several trial authors classify the method as a myofascial release technique. That is the authors' framing and not a measured finding. The proposed fascial and circulatory explanations are discussed under Claimed Uses.
Not Bowen's disease
Searches for Bowen therapy return many records about Bowen's disease, a form of squamous cell skin lesion treated in dermatology, for example with photodynamic therapy. The two subjects share only a surname. Evidence about Bowen's disease says nothing about the bodywork method on this page, and the reverse also holds.
What does Bowen Therapy involve?
How sessions are described
In published trials the practitioner uses the fingers or thumbs to make gentle rolling moves across the direction of the muscle fibers, with the skin stretched or moved before each roll. Moves are followed by a pause of about two minutes. In a Hong Kong neck pain trial sessions lasted 15 to 30 minutes, and in a Pakistani thoracic trial a person lay prone in light, loose clothing and a session lasted 15 to 20 minutes.
The Hong Kong protocols describe the pauses as time for the body to respond and also allowed a pause when the person appeared over-stimulated. These are descriptions of trial protocols, not instructions for practice.
Course length in trials
Course length varies widely. The Hong Kong trials gave eight sessions over 12 weeks, weekly for four sessions and then fortnightly. An Indian fibromyalgia trial used 45-minute weekly sessions for 12 weeks. The thoracic trial gave three sessions a week for four weeks, and a New Zealand trial gave six sessions over eight weeks. At the other extreme a hamstring study used a single treatment, and a stroke case series offered 13 sessions over three months. No source reviewed recommends a standard number of sessions.
Who delivers it
Delivery differs by country. An analysis of 80 Bowen practitioners in an Australian survey network described a small but widely dispersed workforce that treats mostly middle-aged and older clients. In Hong Kong the trial reports say ISBT-certified occupational therapists provide it in government-funded hospitals, and one Pakistani trial took place in a hospital physiotherapy department.
What is Bowen Therapy used for?
What practitioners report treating
In the Australian practitioner survey, the problems that clients most often raised were stress (84.9% of practitioners), neck pain (75.0%) and sciatica (66.0%). These figures describe what practitioners say they see, from a descriptive secondary analysis of 80 people, and they do not show that the method helps with those problems. The authors state that research on the practice of Bowen therapy remains extremely limited.
Conditions that have been studied
Published studies have examined neck pain with myofascial trigger points, fibromyalgia, thoracic myofascial pain, low back pain with hamstring tightness, chronic pain in several body areas, developmental coordination disorder in boys, chronic stroke, and flexibility in people without symptoms. The 2011 systematic review also found reports on frozen shoulder, migraine and multiple sclerosis, mostly in weaker study designs. The number of studies per condition is small.
Proposed explanations
The Hong Kong authors propose that gentle force on restricted fascia may improve blood and lymph flow and support tissue repair. The Pakistani authors describe a principle that gentle movements prompt the body's innate healing mechanisms. These are hypotheses stated in introductions, not tested findings. The one trial that measured mechanisms found no change in measures of the pain-sensing system and some evidence of increased sympathetic nervous system activity, and its authors called the mechanism uncertain.
What does the research show?
Systematic review to 2009
A 2011 systematic review of Bowenwork searched four databases for English-language studies through September 2009 and screened 309 citations. Fifteen met its criteria: one randomized trial, two quasi-experimental studies, three mixed-methods studies, two cross-sectional studies and seven case studies. Over half (53%) reported pain reduction and 33% reported improved mobility. The authors concluded that the evidence was not well documented and that more research was needed before widespread recommendations.
Trials with a sham or placebo comparison
A double-blind trial gave 31 people with chronic multisite pain six sessions of real or sham Bowen therapy over eight weeks. Pain scores were lower with real therapy one week after the course, but not at the final follow-up, and function scores did not differ. In 132 people with fibromyalgia and poor sleep in India, Bowen therapy improved sleep quality and pressure pain threshold compared with a static-touch placebo at 12 weeks.
A crossover trial in healthy university students compared Bowen therapy with a sham procedure on the same day. Pressure pain thresholds rose at two of ten body sites, and its authors described the immediate effects as inconsistent.
Trials against usual care or no treatment
In a Hong Kong trial of 90 people with myofascial neck pain, eight sessions over 12 weeks were compared with continuing usual treatment. Pressure pain threshold, the primary outcome, was higher with Bowen therapy at 12 weeks (adjusted difference 12.83, 95% confidence interval 4.53 to 21.13) and the difference at 24 weeks was borderline (9.10, 0.02 to 18.19; p = 0.050). Neck disability and mood scores were also lower. There was no sham arm.
A later Hong Kong trial in 78 analyzed adults with fibromyalgia found no between-group difference in pain intensity, the primary outcome. Limb endurance was better with Bowen therapy, and pain interference was lower only at the end of the course. Fifteen of 38 controls received acupuncture during the study, compared with one participant in the Bowen group. A single treatment in 120 people without symptoms increased hamstring flexibility over a week compared with no treatment.
Comparisons with other treatments
A Pakistani trial of 30 adults with thoracic myofascial pain compared Bowen therapy with self-applied tennis ball pressure, and pain scores fell more with Bowen therapy. Another trial of 62 people with chronic low back pain and tight hamstrings compared it with muscle energy technique and found no significant difference between the two, with both groups improving. Neither had an untreated or sham group, so the effect of the therapy cannot be separated from time and expectation.
Uncontrolled studies
A pilot study of ten boys aged 8 to 11 with developmental coordination disorder reported better motor scores after six weeks, but no change in psychosocial measures. A case series of 13 people with chronic stroke reported improved gross motor trends and SF-36 scores, but grip strength fell. Neither had a comparison group, and the stroke authors said definite benefit could not be concluded.
What are the criticisms and limits?
Controls and blinding
Most trials had no sham arm, and practitioners and participants cannot be blind to hands-on care. The Hong Kong authors acknowledged that control participants could receive brief health education, other therapies and attention, and that self-reported outcomes carry recall bias. Because of these designs, improvements against usual care may reflect expectation, attention or natural change in addition to any specific effect of the moves.
Size, comparators and conclusions
The trials are small, with 30 to 132 participants, use different comparators and doses, and measure different outcomes. Two sham-controlled trials found short-term or inconsistent effects, and the fibromyalgia trial in Hong Kong found no difference in pain. Some papers use strong wording, such as describing the neck pain trial as confirming efficacy. The numerical results above are better guides to what was found than those conclusions.
Authorship and search limits
Several authors list affiliations with Bowen practice or training bodies: the New Zealand trial's first author lists a Bowen therapy practice and the sham-controlled crossover study lists the International School of Bowen Therapy. These affiliations do not show bias but mean the research is not independent of the field. A PubMed title and abstract search for the main names run on 11 October 2026 returned 27 records and one systematic review specific to Bowen therapy, published in 2011. Other databases were not searched.
What are the safety considerations?
Adverse events reported
The two Hong Kong trials reported that no adverse events related to Bowen therapy occurred, and the stroke case series authors stated that published research to substantiate safety was limited. The abstracts read for the other trials did not report adverse-event data, so for those trials the absence of reports cannot be taken as evidence that none occurred. No systematic review of harms was found. These sources do not allow a frequency of side effects to be estimated.
Who was excluded from trials
The Hong Kong trials excluded people who were pregnant, had major psychiatric illness, malignancy, skin disease in the treated area, infectious disease or severe cardiovascular disease, or who were taking anticoagulants. The fibromyalgia trial also excluded people with a history of major joint or limb surgery. The results therefore do not apply to these groups, and no source reviewed lists formal contraindications.
Care boundaries
In the Hong Kong trials Bowen therapy was added to, or compared with, conventional pain care, and the fibromyalgia authors suggested using it alongside multidisciplinary pain management. Bowen therapy is not a diagnosis, and new, worsening or unexplained symptoms call for medical assessment. It should not delay or replace necessary care.
Training and registers
The Complementary and Natural Healthcare Council in the UK states that applicants for its Bowen register need a training programme that meets the Bowen Therapy National Occupational Standards and Core Curriculum, at a stated qualification level, or three years of relevant experience assessed against those standards. Courses delivered entirely by distance learning do not qualify, and the page lists three approved courses. Registers and standards in other countries were not found in the sources reviewed.
Connected Entries
Showing 8 of 16 related records.
Classification and context
- Entry type
- Modality
- Practice type
- Manual soft-tissue bodywork
- Traditions
- Bowtech lineage, International School of Bowen Therapy lineage
- Concepts
- Cross-fiber moves, Pauses between moves, Move sequences, Fascia, Myofascial pain
- Categories
- Complementary
Sources and discovery context
Research and public-health sources support evidence and safety context. Directory and discovery sources describe navigation, relationships, practitioners, and access—not clinical efficacy.
A review that found one randomized trial among 15 eligible studies and called the evidence not well documented.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the number and design of studies found to September 2009, the proportions reporting pain and mobility benefit, and the search terms used. Must not be read as evidence for any condition, and it predates all the trials cited here.
- Supports sections
- History and Origins, Terminology, Claimed Uses, Research and Evidence
A small double-blind trial that found lower pain than sham at one week but not at final follow-up.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the design, the short-term pain difference at one week, the lack of difference at final follow-up and in function, and the mechanism measures. Must not be generalized beyond 31 people with chronic pain or to long-term effects.
- Supports sections
- Practice Description, Claimed Uses, Research and Evidence
A single-blinded hospital trial with no sham arm in which eight sessions were compared with continuing usual treatment.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports trial design, protocol, effect estimates, exclusions, limitations and the report of no adverse events in 90 randomized people. Must not be read as evidence against sham, for other body areas, or for safety beyond the trial population.
- Supports sections
- History and Origins, Terminology, Practice Description, Claimed Uses, Research and Evidence, Safety and Suitability
A hospital trial in 78 analyzed adults in which pain intensity did not differ between groups.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the design, null primary outcome, secondary outcomes, contamination by other therapies, exclusions and the report that no related adverse events occurred. Must not be read as showing benefit for pain.
- Supports sections
- History and Origins, Terminology, Practice Description, Claimed Uses, Research and Evidence, Safety and Suitability
A 132-person trial in which Bowen therapy was compared with a manual placebo among other arms.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the design, sleep and pressure pain threshold findings against static touch, and the absence of difference for other secondary outcomes. Participants in all groups also did exercises for the second 12 weeks, so 24-week findings cannot be attributed to Bowen therapy alone.
- Supports sections
- Practice Description, Research and Evidence
A crossover study whose authors described inconsistent immediate effects and called for studies in people with symptoms.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports immediate effects in people without symptoms only. Must not be applied to people with pain or to repeated sessions.
- Supports sections
- Research and Evidence
An assessor-blind trial that compared a single treatment with a control group over one week.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a short-term flexibility change after one treatment in 120 people without symptoms. Must not be applied to pain, injury or repeated treatment.
- Supports sections
- Practice Description, Claimed Uses, Research and Evidence
A small convenience-sample trial in adults aged 18 to 40.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a 30-person comparison with self-applied ball pressure over four weeks. Must not be read as comparison with no treatment or sham, and it does not report adverse events in the text read.
- Supports sections
- History and Origins, Practice Description, Claimed Uses, Research and Evidence
A randomized trial in which both techniques were followed by improvement.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a 62-person comparison with muscle energy technique that found no significant between-group difference. Must not be read as showing benefit over no treatment.
- Supports sections
- Claimed Uses, Research and Evidence
A pilot in which motor scores improved and psychosocial scores did not.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a before-and-after change in 10 boys without a comparison group. Must not be used to infer effect or to apply to girls, adults or other conditions.
- Supports sections
- Terminology, Claimed Uses, Research and Evidence
A case series whose authors said definite benefit could not be concluded.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports a 14-person uncontrolled series, its mixed findings, and the authors' statement that published research on safety and effectiveness was limited. Must not be used to infer benefit or to describe safety after stroke.
- Supports sections
- History and Origins, Practice Description, Claimed Uses, Research and Evidence, Safety and Suitability
A descriptive analysis of 80 practitioners from a research network.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports who practices in Australia and what clients practitioners report seeing, from 80 respondents. Must not be read as evidence of outcomes or as representative of practitioners elsewhere.
- Supports sections
- Practice Description, Claimed Uses
A register page listing the standards and the three courses that meet them.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports the UK register's entry route and the courses it lists. Must not be read as describing training or registration in any other country.
- Supports sections
- History and Origins, Terminology, Safety and Suitability
A dermatology review that covers Bowen's disease among superficial skin lesions.
How this source relates
- Source link
- Exact source page
- Relationship
- Supports only that Bowen's disease is a skin lesion discussed in dermatology. Says nothing about Bowen therapy.
- Supports sections
- Terminology
Links to Gyfts Bowen Therapy page for this practice, for discovery only. The platform's descriptions and claims are not independent claims. Machipedia does not rely on them for evidence.
How this source relates
- Source link
- Exact source page
- Relationship
- Links to Gyfts' page for this practice, for discovery only. The platform's descriptions and claims are not independent evidence, and nothing on this Machipedia page relies on them.
- Supports sections
- Practice Description
Consumer health article on this practice; not evidence and not a Machipedia assessment.
How this source relates
- Source link
- Exact source page
- Relationship
- Links to a Healthline article on this practice, as plain-language consumer context only. It is not independent evidence, and nothing on this Machipedia page relies on it.
- Supports sections
- Practice Description